The normal course of treatment is usually 1-2 weeks. It can effectively promote the outward discharge of mucus from the nasal cavity or pharynx or middle ear cavity to reduce the inflammatory myxoma of patients, and is widely used in ENT and respiratory departments in clinical practice. If the patient’s symptoms improve significantly in 1-2 weeks and can be discontinued, if the patient’s condition is longer, such as chronic sinusitis, the patient can be applied for about 1 month, which can be treated more thoroughly. In life, it is recommended that patients exercise more to enhance their resistance to avoid rhinitis, sinusitis or bronchitis, while patients drink more water after using the drug to promote drug absorption and metabolism.